pub 30-day FRN

pub 30-day FRN 2022-08779.pdf

International Research Fellowship Award Program (NIDA)

pub 30-day FRN

OMB: 0925-0733

Document [pdf]
Download: pdf | pdf
24323

Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices
Date: June 16–17, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, 301–272–
4865, [email protected]
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Biomarkers Study Section.
Date: June 16–17, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–357–
9318 [email protected]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 19, 2022.
David W Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–08716 Filed 4–22–22; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request International
Research Fellowship Award Program
of the National Institute on Drug Abuse
(NIDA)
AGENCY:

National Institutes of Health,

HHS.

ACTION:

been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: The
International Research Fellowship
Award Program of the National Institute
on Drug Abuse (NIDA), 0925–0733,
expiration date 07/31/2022,
EXTENSION, National Institute on Drug
Abuse (NIDA), National Institutes of
Health (NIH).
Need And Use of Information
Collection: These programs offer grants
and traineeships necessary for growing
the biomedical researcher workforce,
and the diversity in this workforce. The
application forms collect information of
applicants for selecting those that would
benefit most effectively from the
programs. NIDA is requesting approval
from OMB for application forms to be
used by these programs that will recruit
pre-college through post-doctoral
underrepresented individuals and
individuals of special populations into
the research programs of the Institute for
research training and research
development, for forging mentor/mentee
relationships and networking between
newly funded underrepresented
researchers and experienced
investigators funded by NIDA; and for a
fellowship program to train new
researchers, and support experienced
researchers of other nations, in research
to advance the biomedical and
behavioral science of drug abuse and
addiction while fostering multinational
research in this disease area. The
application forms will be web-based.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
annualized burden hours are 33.

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH) has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Lindsey
Friend, Research Training Program
Officer, NIDA International Program,
National Institute on Drug Abuse,
National Institutes of Health, 3WFN
MSC 6024, 301 North Stonestreet
Avenue, Bethesda, Maryland 20892, or
call non-toll-free number (301) 402–
1428 or email your request, including
your address to: [email protected]
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on February 14, 2022, page
8267 (87 FR 8267) and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
The National Institute on Drug Abuse
(NIDA), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
SUMMARY:

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

khammond on DSKJM1Z7X2PROD with NOTICES

Type of respondent

Number of
responses per
respondent

Average time
per response
(in hours)

Total annual
burden hour

Applicant Scientists ..........................................................................................
Scientists ..........................................................................................................

25
25

1
1

1
20/60

25
8

Total ..........................................................................................................

........................

50

........................

33

VerDate Sep<11>2014

17:01 Apr 22, 2022

Jkt 256001

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

E:\FR\FM\25APN1.SGM

25APN1

24324

Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices

Dated:April 20, 2022
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2022–08779 Filed 4–22–22; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting

khammond on DSKJM1Z7X2PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
This meeting is being held virtually
only; there is no in-person option. The
open sessions will be videocast and may
be accessed by the public from the NIH
Videocasting and Podcasting website
(http://videocast.nih.gov). Individuals
who need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: May 19–20, 2022.
Closed: May 19, 2022, 11:00 a.m. to 12:30
p.m.
Agenda: To review, evaluate, and discuss
internal operations. To review and evaluate
grant applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, Room 987/
989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Open: May 19, 2022, 1:00 p.m. to 5:00 p.m.
Agenda: Report from the Institute Director,
Invited Speaker Presentation, and DPI
Program Update.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, Room 987/
989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Open: May 20, 2022, 1:00 p.m. to 5:00 p.m.

VerDate Sep<11>2014

17:01 Apr 22, 2022

Jkt 256001

Agenda: OSI Program Update; view and
discuss Clearance of Concepts.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, One Democracy Plaza, Room 987/
989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences,
National Institutes of Health One Democracy
Plaza, Room 1072, 6701 Democracy
Boulevard, Bethesda, MD 20892, 301–435–
0809, [email protected]
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting at [email protected]
mail.nih.gov. The statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)

Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
[email protected]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: April 20, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–08721 Filed 4–22–22; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Dated: April 20, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.

National Institutes of Health

[FR Doc. 2022–08715 Filed 4–22–22; 8:45 am]

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; HEAL Initiative:
Developing Quantitative Imaging and Other
Relevant Biomarkers of Myofascial Tissues
for Clinical Pain Management.
Date: May 19–20, 2022.
Time: 11:00 a.m. to 4:00 p.m.

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

National Institute on Aging; Notice of
Closed Meeting

Name of Committee: National Institute on
Aging Special Emphasis Panel; 3D Aging and
Alzheimer Brain Program.
Date: May 31, 2022.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
Ninds, NIH NSC, 6001 Executive Blvd., Suite
3208, MSC 9529, Bethesda, MD 20892, 301–
496–3562, [email protected]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)

E:\FR\FM\25APN1.SGM

25APN1


File Typeapplication/pdf
File Modified2022-04-24
File Created2022-04-24

© 2022 OMB.report | Privacy Policy